Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 11, 2011, Pages 1966-1973

  Costa, Marie Agnès ^a   Girard, Murielle ^a   Dalmay, François ^b   Malauzat, Dominique ^a  

^a CENTRE HOSPITALIER ESQUIROL   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Alcohol dependence; BDNF; Neuronal plasticity; Withdrawal

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DETOXIFICATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE;

ADULT; ALCOHOLISM; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BLOOD CELLS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 80055107310     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2011.01548.x     Document Type: Article

References (93)

1. Angelucci F, Ricci V, Spalletta G, Pomponi M, Tonioni F, Caltagirone C, Bria P (2008) Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers. Eur Neuropsychopharmacol 18:882-887.
2. Asami T, Ito T, Fukumitsu H, Nomoto H, Furukawa Y, Furukawa S (2006) Autocrine activation of cultured macrophages by brain-derived neurotrophic factor. Biochem Biophys Res Commun 344:941-947.
3. Barouch R, Appel E, Kazimirsky G, Brodie C (2001) Macrophages express neurotrophins and neurotrophin receptors. Regulation of nitric oxide production by NT-3. J Neuroimmunol 112:72-77.
4. Bartels C, Kunert HJ, Stawicki S, Kröner-Herwig B, Ehrenreich H, Krampe H (2007) Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol 42:92-102.
5. Beck AT, Beamesderfer A (1974) Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 7:151-169.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
7. Bhang SY, Choi SW, Ahn JH (2010) Changes in plasma brain-derived neurotrophic factor levels in smokers after smoking cessation. Neurosci Lett 468:7-11.
8. Bolaños CA, Nestler EJ (2004) Neurotrophic mechanisms in drug addiction. Neuromolecular Med 5:69-83.
9. Brunoni AR, Lopes M, Fregni F (2008) A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11:1169-1180.
10. Calabrese F, Molteni R, Racagni G, Riva MA (2009) Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34:S208-S216.
11. Castrén E, Rantamäki T (2010) The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 70:289-297.
12. Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M (1997) Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 49:71-81.
13. Crews FT, Buckley T, Dodd PR, Ende G, Foley N, Harper C, He J, Innes D, Loh el-W, Pfefferbaum A, Zou J, Sullivan EV (2005) Alcoholic neurobiology: changes in dependence and recovery. Alcohol Clin Exp Res 29:1504-1513.
14. Crews FT, Nixon K (2009) Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol 44:115-127.
15. Crews FT, Nixon K, Wilkie ME (2004) Exercise reverses ethanol inhibition of neural stem cell proliferation. Alcohol 33:63-71.
16. Davis MI (2008) Ethano-BDNF interactions: still more questions than answers. Pharmacol Ther 118:36-57.
17. Delay J, Pichot P, Lemperiere T, Mirouze R (1963) La nosologie des états dépressifs: rapports entre l'étiologie et la sémiologie. 2. Résultats du questionnaire de Beck. [The nosology of depressive states. Relation between etiology and semeiology. 2. Results of Beck's questionnaire]. Encéphale 6:497-504.
18. Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tessarollo L, Mahadeo D, Sharif S, Kaplan DR, Tsoulfas P, Parada L, Toran-Allerand CD, Hajjar DP, Hempstead BL (1995) Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 147:309-324.
19. D'Souza DC, Pittman B, Perry E, Simen A (2009) Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology (Berl) 202:569-578.
20. Duman RS (2005) Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism. Neurobiol Aging 26:S88-S93.
21. Dwivedi Y (2009) Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat 5:433-449.
22. Ewing JA (1984) Detecting alcoholism. The CAGE questionnaire. JAMA 252:1905-1907.
23. Fiellin DA, Reid MC, O'Connor PG (2000) Screening for alcohol problems in primary care: a systematic review. Arch Intern Med 160:1977-1989.
24. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87:728-734.
25. Gache P, Michaud P, Landry U, Accietto C, Arfaoui S, Wenger O, Daeppen JB (2006) The Alcohol Use Disorders Identification test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res 29:2001-2007.
26. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, Karege F (2005) Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51:234-238.
27. Getachew B, Hauser SR, Taylor RE, Tizabi Y (2008) Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in two rat strains. Pharmcol Biochem Behav 91:97-103.
28. Ghitza UE, Zhai H, Wu P, Airavaara M, Shaham Y, Lu L (2010) Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Behav Rev 35:157-171.
29. Gielen A, Khademi M, Muhallab S, Olsson T, Piehl F (2003) Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients. Scand J Immunol 57:493-497.
30. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255:381-386.
31. González-Pinto A, Mosquera F, Palomino A, Alberich S, Gutiérrez A, Haidar K, Vega P, Barbeito S, Ortiz A, Matute C (2010) Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics. Int Clin Psychopharmacol 25:241-245.
32. Harper C (1998) The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 57:101-110.
33. Heberlein A, Muschler M, Wilhelm J, Frieling H, Lenz B, Gröschl M, Kornhuber J, Bleich S, Hillemacher T (2010) Bdnf and gdnf serum levels in alcohol-dependent patients during withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 34:1060-1064.
34. Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA (2000) Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol 166:127-135.
35. Huang MC, Chen CH, Chen CH, Liu SC, Ho CJ, Shen WW, Leu SJ (2008) Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol 43:241-245.
36. Huang TL, Lee CT (2006) Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J Psychiatr Res 40:664-668.
37. Jeanblanc J, He DY, Carnicella S, Kharazia V, Janak PH, Ron D (2009) Endogenous BDNF in the dorsolateral striatum gates alcohol drinking. J Neurosci 29:13494-13502.
38. Jeanblanc J, He DY, McGough NN, Logrip ML, Phamluong K, Janak PH, Ron D (2006) The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption. J Neurosci 26:1457-1464.
39. Joe KH, Kim YK, Kim TS, Roh SW, Choi SW, Kim YB, Lee HJ, Kim DJ (2007) Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. Alcohol Clin Exp Res 31:1833-1838.
40. Kalivas PW, O'Brien C (2008) Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33:166-180.
41. Kalman D, Morissette SB, George TP (2005) Am co-morbidity of smoking in patients with psychiatric and substance use disorders. J Addict 14:106-123.
42. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM (2002a) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148.
43. Karege F, Schwald M, Cisse M, Bertschy G, Aubry JM (2002b) Postnatal developmental profile of brain-derived neurotrophic in rat brain and platelets. Neurosci Lett 109:143-148.
44. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865-870.
45. Kim TS, Kim DJ, Lee H, Kim YK (2007) Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neurosci Lett 23:53-57.
46. Kimata H (2003) Kissing reduces allergic skin wheal responses and plasma neurotrophin levels. Physiol Behav 80:395-398.
47. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H, Pedersen BK (2007) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50:431-438.
48. Lee BC, Choi IG, Kim YK, Ham BJ, Yang BH, Roh S, Choi J, Lee JS, Oh DY, Chai YG (2009) Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. Alcohol 43:265-269.
49. Le Strat Y, Ramoz N, Gorwood P (2010) In alcohol-dependent drinkers, what does the presence of nicotine dependence tell us about psychiatric and addictive disorders comorbidity? Alcohol Alcohol 45:167-172.
50. Lewin GR, Barde YA (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317.
51. Logrip ML, Janak PH, Ron D (2008) Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J 22:2393-2404.
52. Logrip ML, Janak PH, Ron D (2009) Escalating ethanol intake is associated with altered corticostriatal BDNF expression. J Neurochem 109:1459-1468.
53. Lommatzsch M, Braun A, Mannsfeldt A, Botchkarev VA, Botchkareva NV, Paus R, Fischer A, Lewin GR, Renz H (1999) Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived neurotrophic functions. Am J Pathol 155:1183-1193.
54. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115-123.
55. Marticnowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33:73-83.
56. Mayfield D, McLeod G, Hall P (1974) The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 131:1121-1123.
57. McClung CA, Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacol Rev 33:3-17.
58. McGough NNH, He DY, Logrip ML, Jeanblanc J, Phamluong K, Luong K, Kharazia V, Janak PH, Ron D (2004) RACK-1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci 24:10542-10552.
59. McPherson A, Martin CR (2010) A narrative review of the beck depression inventory (BDI) and implications for its use in an alcohol dependent population. J Psychiatr Ment Health Nurs 17:19-30.
60. Mikhailidis DP, Jenkins WJ, Barradas MA, Jeremy JY, Dandona P (1986) Platelet function defects in chronic alcoholism. Br Med J (Clin Res Ed) 293:715-718.
61. de la Monte SM, Longato L, Tong M, DeNucci S, Wands JR (2009) The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids. Int J Environ Res Public Health 6:2055-2075.
62. Moonat S, Starkman BG, Sakharkar A, Pandey SC (2010) Neuroscience of alcoholism: molecular and cellular mechanisms. Cell Mol Life Sci 67:73-88.
63. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, Sun B (2000) Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470:113-117.
64. Niemelä O (2007) Biomarkers in alcoholism. Clin Chim Acta 377:39-49.
65. Nixon K, Kim DH, Potts EN, He J, Crews ET (2008) Distinct cell proliferation events during abstinence after alcohol dependence: microglia proliferation precedes neurogenesis. Neurobiol Dis 31:218-229.
66. Nockher WA, Renz H (2006) Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J Allergy Clin Immunol 117:583-589.
67. Noga O, Englmann C, Hanf G, Grutzkau A, Seybold J, Kunkel G (2003) The production, storage and release of the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics and non-allergics. Clin Exp Allergy 33:649-654.
68. Noga O, Hanf G, Schaper C, O'Connor A, Kunkel G (2001) The influence of inhalative corticosteroids on circulating nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in allergic asthmatics. Clin Exp Allergy 31:1906-1912.
69. Ostacher MJ (2007) Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment. Psychiatr Clin North Am 30:69-76.
70. Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R (1999) Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport 10:557-561.
71. Pettinati HM (2004) Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry 56:785-792.
72. Poirier MF, Canceil O, Baylé F, Millet B, Bourdel MC, Moatti C, Olié JP, Attar-Lévy D (2002) Prevalence of smoking in psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry 26:529-537.
73. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90:397-406.
74. Ramirez D, Darne B, Lombrail P, Athuil L, Crnac J, Lévy S, Rueff B (1990) Prévalence des maladies alcooliques dans un hôpital universitaire de la banlieue parisienne. Presse Med 19:1571-1575.
75. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, Secher NH, Pedersen BK, Pilegaard H (2009) Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 94:1062-1069.
76. Reynaud M, Malet L, Facy F, Glanddier P (2000a) Hospital morbidity of alcohol use disorders in the center of France. Alcohol Clin Exp Res 24:1057-1062.
77. Reynaud M, Schellenberg F, Loiseaux-Meunier MN, Schwan R, Maradeix B, Planche F, Gillet C (2000b) Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV). Alcohol Clin Exp Res 24:1414-1419.
78. Rizos EN, Papadopoulou A, Laskos E, Michalopoulou PG, Kastania A, Vasilopoulos D, Katsafouros K, Lykouras L (2010) Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry 11:251-255.
79. Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, Danker-Hopfe H, Gass P (2009) Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42:270-276.
80. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection persons with harmful alcohol consumption. Addiction 88:791-804.
81. Scholz J, Klein MC, Behrens TE, Johansen-Berg H (2009) Training induces changes in white-matter architecture. Nat Neurosci 12:1370-1371.
82. Schulte-Herbrüggen O, Braun A, Rochlitzer S, Jockers-Scherübl MC, Hellweg R (2007) Neurotrophic factors-a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases? Curr Med Chem 14:2318-2329.
83. Schwan R, Albuisson E, Malet L (2004) The use of biological laboratory markers in the diagnosis of alcohol misuse: an evidence-based approach. Drug Alcohol Depend 74:273-279.
84. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70-75.
85. Stevenson JR, Schroeder JP, Nixon K, Besheer J, Crews FT, Hodge CW (2009) Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology 34:1209-1922.
86. Sullivan EV, Rosenbloom MJ, Pfefferbaum A (2000) Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 24:611-621.
87. Takeuchi H, Sekiguchi A, Taki Y, Yokoyama S, Yomogida Y, Komuro N, Yamanouchi T, Suzuki S, Kawashima R (2010) Training of working memory impacts structural connectivity. J Neurosci 30:3297-3303.
88. Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, Someya T, Nawa H (2002) Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 110:249-257.
89. Umene-Nakano W, Yoshimura R, Ikenouchi-Sugita A, Hori H, Hayashi K, Ueda N, Nakamura J (2009) Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence. Hum Psychopharmacol 24:409-413.
90. Ward RJ, Lallemand F, de Witte P (2009) Biochemical and neurotransmitter changes implicated in alcohol-induced brain damage in chronic or 'binge drinking' alcohol abuse. Alcohol Alcohol 44:128-135.
91. Wojnar M, Brower KJ, Strobbe S, Ilgen M, Matsumoto H, Nowosad I, Sliwerska E, Burmeister M (2009) Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin Exp Res 33:693-702.
92. Yang ZF, Ho DW, Lam CT, Luk JM, Lum CT, Yu WC, Poon RT, Fan ST (2005) Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res 65:219-225.
93. Yang ZF, Ho DW, Lau CK, Tam KH, Lam CT, Yu WC, Poon RT, Fan ST (2006) Significance of the serum brain-derived neurotrophic factor and platelets in hepatocellular carcinoma. Oncol Rep 16:1237-1243.